Author Correction: Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy of Chronic Lymphocytic Leukemia
Overview
Molecular Biology
Authors
Affiliations
Mechanisms of antigen-dependent resistance to chimeric antigen receptor (CAR)-T cell therapies.
Nasiri F, Safarzadeh Kozani P, Salem F, Mahboubi Kancha M, Dashti Shokoohi S, Safarzadeh Kozani P Cancer Cell Int. 2025; 25(1):64.
PMID: 39994651 PMC: 11849274. DOI: 10.1186/s12935-025-03697-y.
The Emerging Role of Induced Pluripotent Stem Cells as Adoptive Cellular Immunotherapeutics.
Mehra V, Chhetri J, Ali S, Roddie C Biology (Basel). 2023; 12(11).
PMID: 37998018 PMC: 10669440. DOI: 10.3390/biology12111419.
Light-inducible T cell engagers trigger, tune, and shape the activation of primary T cells.
Jaeger M, Anastasio A, Chamy L, Brustlein S, Vincentelli R, Durbesson F Proc Natl Acad Sci U S A. 2023; 120(39):e2302500120.
PMID: 37722050 PMC: 10523538. DOI: 10.1073/pnas.2302500120.
Mehra V, Agliardi G, Dias Alves Pinto J, Shafat M, Garai A, Green L J Immunother Cancer. 2023; 11(9).
PMID: 37709295 PMC: 10503365. DOI: 10.1136/jitc-2023-007002.
Role of CAR T Cell Metabolism for Therapeutic Efficacy.
Rial Saborido J, Volkl S, Aigner M, Mackensen A, Mougiakakos D Cancers (Basel). 2022; 14(21).
PMID: 36358860 PMC: 9658570. DOI: 10.3390/cancers14215442.